BERLIN (Reuters) – Bayer (DE:) is considering stopping sales of the weedkiller glyphosate to private users who apply it in their gardens, German newspaper Handelsblatt reported on Thursday, citing financial and corporate sources.
The business daily said the move was part of ongoing talks with tens of thousands of plaintiffs in the United States about an out-of-court settlement. The plaintiffs blame Bayer’s glyphosate-based weedkillers for their cancer.
Bayer was not immediately available for comment.
Court-appointed mediator Ken Feinberg, who leads the settlement discussions, has put the number of Roundup cancer claimants at more than 75,000 while Bayer has said the claims it has been served with in court were below 50,000.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.